A competitive enzyme immunoassay for apolipoprotein A-II was developed. Microtitre plates were used äs a solid phase and coated with anti-apolipoprotein A-II antibodies. Purified apolipoprotein A-II, labelled with horseradish peroxidase was used äs competing ligand.
Introduction
Epidemiological results showing a negative correlation between plasma high density lipoprotein (HDL) cholesterol levels and the incidence of coronary heart disease have caused an increased awareness of the value of HDL determinations in the evaluation of the individual coronary risk. This has led in recent years to the development of immuiioassays for the apolipoproteins of HDL. An especially large number of studies has been devoted to the quantification of the apolipoproteins A-I and A-II which together account for 90 percent of the total protein content of HDL. A number of quantitative assays such äs single radial immunodiffusion (l, 2, 3), rocket immunoelectrophoresis (4) and radioimmunoassay (5-10) for apolipoprotein A-II have been described. Considering the considerable discordances between the reported normal apolipoprotein A-II values (1 -10) , it appears that this apolipoprotein has been difficult to quantify.
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Here we report the development of an enzyme immunoassay for apolipoprotein A-II. The enzyme immunoassay technique shares with the radioimmunoassay several important advantages compared with single radial immundiffusion and rocket immunoelectrophoresis, such äs sensitivity, the small amount of antiserum required, and the large number of samples which can be handled in each assay. Relative to the radioimmunoassay, the enzyme immunoassay benefits from low Investment costs, stability of reagents and absence of biohazards associated with the handling of radioactive materials. It therefore seemed appropriate to try this technique for the estimation of apolipoprotein A-II concentrations in serum.
The residue was finally dried under N 2 and the delipidated HOL was fractionated by Sephacryl S 300 in 6 mol/1 urea, 0.05 mol/i Tris-HCl pH 8.6. The fractions corresponding to apolipoprotein A-II were further purified after lyophilisation by chromatography on DEAE-Trisacryl in 6 mol/1 urea employing a linear gradient (0.001 mol/1 Tris-HCl pH 8.6-0.02 mol/1 tris-HCl pH 8.6),Fractions corresponding to apolipoprotein A-II were extensively dialyzed agäinst 0.001 mol/1 NH 4 HCO 3 and lyophllized. A final purification step was carried out by preparative polyacrylamide electrophoresis (12) . The purified apolipoprotein A-II yielded a single band on polyacrylamide gel electrophoresis in sodium dodecyl sulphate (SDS) (12) .
Preparation of apolipoprotein A^II antisera
Rabbits were immunized at multiple intradermal sites with l mg apolipoprotein ^ mixed with complete Freund'* -adjuvant. At intervals of 3 weeks, the animals received booster doses, consisting of half the dose of antigen and incomplete Freund?* adjuvant. Animals were bled after 12 weeks. The antisera were monpspecific äs tested by double diffusion in agarose.
Materials and Methods

Materials
Horseradish peroxidäse (EC 1.11.1.7. Reinheitszahl ca. The assays were performed in 96-well, round-bottomed microtitre plates M-124 B from Flow Laboratories, FRG.
All other reagents were analytical grade.
Reagents
Carbonate-hydrogencarbonate buffer:
1.6 g/l sodium carbonate and 2.95 g/l sodium hydfogencarbonate pH 9.6. This buffer should be made up freshly every week.
Phosphate-buffered saline containing Tween:
1.48 g of disodium hydrogen phosphate, 0.43 gof potassium dihydrogen phosphate, 8.77 g of sodium Chloride and 0.5 ml Tween 20 were dissolved in 800 ml of distilled water. After adjustment of the pH to 7.2, the solution was diluted to 11 with distilled water.
Phosphate-citrate buffer:
8.52g of disodium hydrogen phosphate and 5.25g of citric acid were dissolved in 800 ml of distilled water. After adjustment of the pH to 5.0, the solution was diluted to 11 with distilled water.
Chromogen solution:
The Substrate solution was made up immediately before use. 15 mg of o-phenylenediamine were dissolved in 100 ml of the above phosphate-citrate buffer and 40 of hydrogen peroxide (300 g/l) were added.
Preparation of apolipoprotein A-II HDL (1.063 < d < 1.21 kg/l) was isolated by sequential ultracentnfugation from normolipaemic individual donors and was delipl· datedbyethanol-ether(volumes,300ml + 200ml)ät-10°C(ll).
Preparation of the apolipoprotein -^ € conjugate Apolipoprotein A-II was labelled with horseradish peroxidase according to the method of Näkane et al. (13) . The apolipoprotein A-II-enzyme conjugate was isolated by passing through a 100 x 2.5 cm column of Sephacryl S 200. The first peak was collected and concentrated in an Amicon cell using a PM 10 filter. After addition of bovine albumin and merthiolate to a final cpncentration of 10 g/l aiid 0.1 g/l respectively, the apolipoprotein A-IIenzyme conjugate was stored at 4°C.
Standards
Dilutipns of a serum pool in phosphate buffered saline/Tween containing 10 g/l bovine serum albumin and 0.1 g/l merthiolate were used äs apolipoprotein A-II Standards.
To deterraine the apolipoprotein A^II cöntent qf the serum pöol, HDL (l .063 < d < l .21 g/l) was isolated by sequential ultracentrifugation (14) and its apoprotein cöntent measured by the method of Lowry (15), using bovine serum albumin äs a Standard; the apolipoprotein -contributipn to the HDL protein was äs? sumed to be approximately 0,20 (5, 6, 9, 10).
Enzyme immunoassay procedure
The typical enzyme immunoassay was carried out in the follpwing way. Each well of a microtitre plate was filled with 0.1 ml of a solution of 50 mg/1 anti-apolipoprotein A-Ü IgG in carbonate-hydrogencarbohate 'buffer pH 9.6. IgG had been isolated ipreviously from the anti-apolipoprotein A-II-antiserum by ammonium sulphate precipitatipn and DEAE-Trisacryl chromatography. The microtitre plates were covered with parafilm and incubated for 3 hours at 37 °C. The contents of the plates were then aspirated and dried in an air stream at room temperature for approximately 15 minutes, then washed 7 times with phosphate buffered saline/ Tween. The plate filled with phosphate buffered saline/Tween was then incubated for approximately 10 minutes at 37 °C to enhance the desorption of all IgG not strongly fixed to the walls öf the plate wells. Hinally the plate was washed again 3 times with phosphate buffered saline/Tween. Standard or serum was diluted 1:1000 with phosphate buffered saline/Tween containing 10 g/l bovine serum albumin and 0.1 g/l merthiolate. Apolipoprotein A-II-enzyme conjugate was diluted 1:50 with phosphate buffered saline/Tweeii containing 10 g/l bovine serum albumin. 50 ul diluted Standard or serum were mixed with 50 ul diluted apolipoprotein Arll-enzyme conjugate and added in duplicate to each well of a coated microtitre plate, with the exception .of the wells belonging to the externäl rows of the plate, which? were left free. The covered plates were incubated for 4 hours at 30 °C. The contents were then aspirated and the plates were washed 7 times with phosphate buffered saline/Tween. 0.1 ml of chromogen solution was pipetted into each well and the plate was left at room temperature in the dark. After 30 minutes, 0.1 ml of 250 g/kg hydrochloric acid was added to each well and the absorbance was measured within 30 minutes at 492 nm. As a blank 0.1 ml unreacted chromogen solution with 0.1 ml 250 g/kg hydrochloric acid was used. The results were expressed s a fraction of the absorbance at 492 nm when no competing antigen was present (i.e. B/B ). 
Results
Optimizing assay conditions
Effect of different amounts ofanti apolipoprotein ΑΊΙ IgG to coat the microtitre plate wells 0.1 ml of anti apolipoprotein A-II IgG in different amounts between 20 and 100 mg/1 diluted in carbonate-hydrogen carbonate buffer was· dispensed into the wells of a microtitre plate and incubated for 3 hours at 37 °C. After washing, the plates were.used s in the typical enzyroe immunoassay procedure. The results are shown in figure 1. 
Effect of different dilutions of apolipoprotein A-II-enzyme conjugate
50 μΐ of apolipoprotein A-II-enzyme conjugate diluted between 1/33 and 1/400 were added to 50 μΐ of a series of Standards and the mixture was dispensed into coated microtitre plate wells. The typical enzyme immunoassay procedure was then followed. The results are shown in figure 2. Coating of the plates with 50 ing/1 anti-apolipoprotein A^H IgG, and a dilution of 1/50 for apolipoprotein A-II-enzyme conjugate were selected s optimal for econpmy, pfecision and displacement of labelled apolipoprotein A-II. 
Specificity
The cross-reactivity with purified apolipoprotein A-I was about 1%. As demonstrated by the displacement produced by isolated LDL.and VLDL, the crossreactivity with these lipoprotein fractions was only jninimal in the working ränge of the assay (fig. 4 ).
Precision
To assess the precision of the assay, 3 serum pools containing high, medium and low amounts of apolipoprotein A-II were used. The intra-assay coefficient of Variation was estimated by 20 replicated analyses of apolipoprotein A-II in the three serum pools. The inter-assay coefficient of Variation was estimated by making duplicate analyses in the 3 pools on 10 different days. The results are shown in tab. 2. In our assay, we preferred to use äs a Standard whole serum whose apolipoprotein -content had been estimated with a ireasonäble äppf orimation. The apolipoprotein A-II mass of HOL has generally been found to represent 0.20 of the total apoprotein (5, 6, 9, 10) , and interestingly in all forms of hyperlipidaemia the proportion of apolipoprotein A-II in HDL was found to be unaltered (16) .
Discussion
Tab. 2. Intra^ and inter-assay precision (serum pool)
Intra-assay precision
In their radioimmunoassay for apolipoprotein A-II, Goldberg et al. (6) found that in a logit-log plot, serum dilutions produced displacement curves that were not parallel to those of purified apolipoprotein A-II and they observed a more effective displacement of iodinated apolipoprotein A-II by increasing doses of purified apolipoprotein A-II than by whole serum. Karlin et al. (17) also pointed out the nonparallelism between dilutions of HDL and purified apolipoprotein A-II, but noted a less effective displacement by purified HDL apolipoproteins than by HDL. In general we observed in our assay an acceptable parallelism between purified apolipoprotein A-II and diluted serum. Nevertheless, äs mentioned previously, we preferred to use dilutions of a serum pool äs Standards.
It has been reported several times that in contrast to apolipoprotein A-I, delipidation of serum did virtually not appear to expose additional antigenic determinants of apolipoprotein A-II (5, 7, 9). Our results of delipidation confirmed this and made a delipidation step of the serum samples before assay unnecessary.
The sensitivity of our single antibody method using specific anti-apolipoprotein A-II IgG bound to a solid phase, was relatively low compared with the sensitivity of a double antibody radioimmunoassay described previously (5) . This feature of the assay, however, made it possible to avoid the very high dilutions of the serum samples which were necessary in the radioimmunoassay. For optimal precision of the assay, the following methodical details were important. First, because of their Variation in protein adsorption (18, 19 ) the external rows of the microtitre plate were not used. Second, coating of the plate with excessive amounts of anti-apolipoprotein A-II IgG was avoided since this resulted in a loss of precision. Third, the plates were coated with no more than 0.1 ml of IgG solution in carbonate-hydrogen carbonate buffer and the total volume of sample plus apolipoprotein-enzyme conjugate amounted also to 0.1 ml. This ensured that no labelled or unlabelled apolipoprotein A-II became bound to antibody fixed at the upper part of the well during the washing procedure. Fourth, the plate was coated at 37 °C, then dried in an air stream and during the washing procedure incubated at 37 °C. During the incubation with Standard or sample and apolipoprotein-enzyme conjügate, however, the temperature was limited to 30 °C. This caused a net improvement of the precision, probably by reducing the desorption of anti-apoiipoprotein A-II IgG from the plates during the incubation with sample and apolipoprotein-enzyme conjügate. In order to appreciate the predictive ability of apolipoproteins in the evaluation of the risk of coronary heart disease, simple, fast, reliable and precise methods for the assay of apolipoproteins are required. The enzyme immunoassay is characterised by minimal demands on equipment and technical expertise and may be adapted for the quantification of apolipoprotein A-II in clinical routine. The preparation of a suitable Standard, however, deserves further studies.
